Skip to main content
Clinical Trials/NCT02899507
NCT02899507
Completed
Phase 4

Prophylactic Versus Clinically-driven Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest

University Medical Centre Ljubljana1 site in 1 country60 target enrollmentSeptember 2013

Overview

Phase
Phase 4
Intervention
Amoxicillin-Clavulanic acid
Conditions
Out-of-hospital Cardiac Arrest
Sponsor
University Medical Centre Ljubljana
Enrollment
60
Locations
1
Primary Endpoint
Value of C-reactive protein (CRP) at day three
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine whether there is potential benefits of prophylactic antibiotic treatment in comatose survivors of out-of-hospital cardiac arrest (OHCA) treated in intensive care unit with therapeutic hypothermia.

Detailed Description

Postresuscitation management of comatose survivors of out-of-hospital cardiac arrest (OHCA) significantly improved and "bundle of care" including therapeutic hypothermia, immediate coronary angiography, percutaneous coronary intervention (PCI) and contemporary intensive care nowadays leads to survival with good neurological recovery. Benefit of prophylactic antibiotics, which may suppress development of postresuscitation infection and especially early onset pneumonia and thereby decrease the severity of postresuscitation systemic inflammatory response, is controversial. Because of these uncertainties, the investigators performed a single-center randomized clinical trial comparing prophylactic versus clinically-driven administration of antibiotics in comatose survivors of OHCA. The investigators hypothesized that prophylactic antibiotics may decrease the severity of postresuscitation systemic inflammatory response by reducing the incidence of postresuscitation infection and especially pneumonia which was further addressed by repeat microbiological sampling.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
April 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marko Noc

MD, PhD

University Medical Centre Ljubljana

Eligibility Criteria

Inclusion Criteria

  • Female and male over 18 years old
  • Comatose survivors of out-of-hospital cardiac arrest treated in intensive care unit with therapeutic hypothermia

Exclusion Criteria

  • Suspected or confirmed pregnancy
  • Allergy to amoxicillin-clavulanic acid
  • Tracheobronchial aspiration
  • Antibiotic therapy before cardiac arrest
  • Need of antibiotics due to other causes
  • Candidates for immediate veno-arterial extracorporeal membrane oxygenation (VA ECMO)
  • Patients in whom no active treatment was decided on admission

Arms & Interventions

Prophylactic antibiotic

Amoxicillin-Clavulanic acid 1.2g every 8h

Intervention: Amoxicillin-Clavulanic acid

Outcomes

Primary Outcomes

Value of C-reactive protein (CRP) at day three

Time Frame: Three days after admission to Intensive care unit (ICU)

Expressed in milligram/litre (normal \<5 mg/L)

Secondary Outcomes

  • Appearance of pneumonia on chest X ray(Chest X ray was taken on admission and afterwards on daily basis during the stay in the intensive care unite but not longer than first week)
  • Duration of mechanical ventilation(From the admission until spontaneous breathing . This was during ICU stay-one month)
  • Survival with good neurological outcome(Up to six months after the event)
  • Severity of systemic inflammatory response estimated by peak value of neutrophil Cluster of differentiation 64 (CD 64)(First measurement at admission in hospital and afterwards in 24 hours intervals in the first three days)
  • Severity of systemic inflammatory response estimated by peak white blood cell count (WBC)(First measurement at admission in hospital and afterwards in 24 hours intervals during stay in the intensive care unite (ICU) but not longer then first seven days)
  • Severity of systemic inflammatory response estimated by peak value of procalcitonin (PCT)(First measurement at admission in hospital and afterwards in 24 hours intervals during stay in the intensive care unite (ICU) but not longer then first seven days)
  • Incidence of positive hemocultures(From the admission until the patient was transferred to the ward. This was always during the ICU stay-one month)
  • Duration of tracheal intubation(From the day of admission until the extubation. This was always during the ICU stay- one month)
  • Incidence of positive blind mini bronchoalveolar lavage (Mini-BAL) on day 3(Mini-BAL was performed on the third day after the sudden cardiac arrest)
  • ICU stay(From the admission until the patient was transferred to ward, usually less than one month)

Study Sites (1)

Loading locations...

Similar Trials